Minerva Neurosciences Inc (NERV.OQ)

NERV.OQ on NASDAQ Stock Exchange Global Market

4.33USD
21 Nov 2014
Price Change (% chg)

$-0.14 (-3.13%)
Prev Close
$4.47
Open
$4.47
Day's High
$4.47
Day's Low
$4.27
Volume
1,651
Avg. Vol
6,496
52-wk High
$7.90
52-wk Low
$4.10

NERV.OQ

Chart for NERV.OQ

About

Minerva Neurosciences, Inc. is a biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (CNS), diseases. The Company’s product candidates are MIN-101, a compound it is developing for the treatment of patients with... (more)

Overall

Beta: --
Market Cap (Mil.): $81.13
Shares Outstanding (Mil.): 18.44
Dividend: --
Yield (%): --

Financials

  NERV.OQ Industry Sector
P/E (TTM): -- 269.72 39.20
EPS (TTM): -4.35 -- --
ROI: -145.55 -1.77 17.16
ROE: -179.59 -3.18 18.09
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks